TIPE3 and metastatic malignant neoplasm in the lymph nodes: Patients with late-stage (TNM III-IV) or with lymph node metastasis patients had lower TIPE3 mRNA levels than those with early-stage (TNM I-II) or without lymph node metastasis ones, respectively (Supplementary Fig. 2A, B).